Joint & Bone Initiative

Research & Business Advisory Committee (RBAC)

The Research and Business Advisory Committee (RBAC) reflects a broad cross-section of external members with diverse affiliations and expertise and provides overall direction and advice to the BJI Executive Committee with regard to scientific priorities, business development, and commercialization opportunities locally, nationally, and internationally. (See Terms of Reference below.)

Primary Goal

Western’s Bone and Joint Institute (BJI) Research and Business Advisory Committee (RBAC) provides overall direction and advice to the BJI Executive Committee with regard to scientific priorities, business development, and commercialization opportunities locally, nationally, and internationally.

Membership

To the greatest extent possible, RBAC membership reflects a broad cross-section of external (non-Western) members that are diverse in terms of relevant expertise, gender, culture, sectors, and public/private organizations. Members of the RBAC are appointed annually by the BJI Executive Committee based on recommendations from the BJI Governing Board and Operations Committee. Total membership should not exceed 15 members including the Chair and the Vice-Chair at any one time.

The Scientific Director and Manager of Research and Innovation are non-voting, ex-officio members of the RBAC, and not eligible to serve as its Chair or Vice-Chair. Other internal (affiliated with Western) members are non-voting, ex-officio members of the RBAC, but are eligible to serve as its Chair or Vice-Chair. BJI Governing Board members are not eligible to serve on RBAC. The chair of the RBAC will serve as the RBAC representative on the BJI Governing Board.

Note: Membership is in a volunteer capacity. BJI officers, committee members and participants will not be remunerated. External members of RBAC will receive a small honorarium and travel expenses for the annual meeting, in accord with the University’s Travel & Expenses Reimbursement Policy.

Terms

RBAC members will serve a 2-year term that is renewable. The RBAC will elect a Chair and Vice-Chair from within its own ranks that will normally serve a 2-year term, with the possibility for renewal. To maintain continuity, committee appointments will be staggered so that approximately one-third of members will be considered for replacement or re-appointment each year.

Frequency of Meetings

Annual RBAC meetings will be held in person and/or electronically (i.e. tele/web conferencing). At the call of the RBAC chair, additional electronic meetings may be held as needed. Occasionally, members of the RBAC may be consulted individually by Institute members or staff for specific advice or guidance.

Quorum

Quorum is a majority of members (50% +1). The RBAC is expected to operate by consensus. When consensus cannot be reached, the Chair will consult the Institute By-Laws and Procedures.

Conflict of Interest


Members are: (a) required to disclose any conflict or potential conflict, and (b) prohibited from discussing/voting on any matter in which there is a conflict. Potential conflicts of interest should be disclosed prior to meetings and/or prior to discussion of the specific issue. Members in conflict will normally be expected to leave the meeting while the specific issue is discussed.

Mandate

The RBAC is responsible for:

  • providing advice regarding scientific priorities, business development and commercialization, educational programs, knowledge translation and exchange, and overall direction of the Institute;
  • suggesting innovative approaches to promote transdisciplinary collaborative research; enhance success in applications for major funding; foster outreach, multi-sectoral partnerships and globalization; improve communications; and evaluate performance;
  • reviewing the Institute’s annual report with recommendations passed on to the BJI Executive Committee for consideration; and
  • providing guidance and assistance with Institute sustainability.

Evaluation and Revision of the Terms of Reference

RBAC terms of reference and membership shall be reviewed by the BJI Governing Board annually to ensure adequate adherence to Western University’s policy #7.9 and Institute requirements. The current terms were approved by the BJI Governing Board July 31, 2016.

Source

Sections 3 of the Bone and Joint Institute 2015 Annual Report at Western University (June 2016), subsection 5.1 of the designation proposal at Western University (August 2014), and Western University’s Manual of Administrative Policies and Procedures, policy 7. 9 (June 26, 2014).

Dave Barrett

Executive Director of Ivey International Centre for Health Innovation

Ex-Officio

Clifton Bingham

Director of Johns Hopkins Arthritis Centre

Appointed Member

Jenn Boyle



Consumer Rep

Lisa Cechetto

Executive Director of WORLDiscoveries

Ex-Officio

John Coderre



Consumer Rep

Kurt Hankenson

Associate Director of Laboratory for Comparative Orthopaedic Research

Appointed Member

Patrick Henry

Business Unit Director, ASD Smith & Nephew

Appointed Member

Cathie Hofstetter



Consumer Rep

David Holdsworth

Scientific Director of Western's Bone and Joint Institute

Ex-Officio

Reiza Rayman

President Titan Medical

Appointed Member

Carl Richards

Director of the McMaster Immunology Research Centre

Appointed Member

Ron Zernicke

Centre for Hip Health and Mobility

Appointed Member

Jann Paquette-Warren

Manager of Research & Innovation

Ex-Officio